If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Contract Win

21 Jul 2009 09:21

RNS Number : 0059W
ViaLogy PLC
21 July 2009
 



ViaLogy plc ("ViaLogy")

ViaLogy joins with University of Texas and a large Texas Oil Independen

to analyze oil prospect

LondonJuly 21, 2009Vialogy (LSE: VIY) ViaLogy announces that it has signed a services contract with a large privately owned oil Independent based in MidlandTexas. The company drills over 40 wells per year.  Under this contract ViaLogy will provide reservoir sizing and drilling recommendations for an 11,000 feet deep Strawn formation prospect located in the Midland Basin in the heart of the Wolfberry play. The Wolfberry is currently one of the most active plays in the Permian basin. For competitive reasons the firm has declined to be publicly identified or to provide further project details.

According to the company's Chief Geophysicist"The Strawn formation is one of the more enigmatic hydrocarbon producing stratigraphic formations, as production rates can vary significantly over small regions. Well completion costs are high and we need more innovative computational approaches to characterize the subsurface and develop drilling targets. We are looking forward to ViaLogy's QuantumRD technology to assess subtle porosity variations and size hydrocarbon deposits on our block to mitigate risk."

ViaLogy will be collaborating on this project with seismic expert Prof. Bob Hardage and his geophysics team at the world renowned Bureau of Economic Geology (BEG) at the University of Texas at Austin. Prof. Hardage founded the Exploration Geophysics Laboratory (EGL) (http://www.beg.utexas.edu/indassoc/egl) currently focused on the development and application of multi-component seismic imaging. He has also collaborated with this independent in surveying and analyzing this prospect in the past. Bob Hardage commented, “We are very interested to apply ViaLogy technology to deliver better formation characterization from high quality 3D seismic and multi-component seismic surveys for tight sand-shale sequences. Results could have broad applicability in developing numerous reservoir systems”.

ViaLogy's deliverables will include characterization of hydrocarbon reservoir boundaries, subsurface formations, lithology, and depth, as well as porosity estimates, and recommended drill locations. 

ViaLogy CEO Robert Dean stated, "This is a significant and challenging opportunity to demonstrate our technology with a key independent, and to work hand-in-hand with the prestigious BEG in areas where conventional seismic analysis has proven to be limited. A successful outcome will move us closer to our goal of widespread industry acceptance of QuantumRD. At that point, we will be free to disclose the client and detailed results from the work. Multi-component seismic data is being increasingly collected by the E&P players for high thrust and carbonate reservoirs. Extracting more information from multi-component seismic opens up several new business opportunities for ViaLogy".

Further information from:

ViaLogy

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756) 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy +44 (0) 20-7107-8000 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com.

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEASAFSUSEFW
Date   Source Headline
30th Nov 201511:20 amRNSNotice of Results
12th Nov 20157:00 amRNSPositive independent study results for IONA test
28th Oct 20157:00 amRNSAppointment to the Board
15th Oct 20153:56 pmRNSWorld first: in-house antenatal reflex screening
14th Oct 20157:00 amRNSClinical laboratory with expanded capacity opened
14th Oct 20157:00 amRNSHolding(s) in Company
13th Oct 20154:08 pmRNSResult of AGM
13th Oct 20152:20 pmRNSHolding(s) in Company
13th Oct 20157:01 amRNSAGM Statement
13th Oct 20157:00 amRNSPremaitha collaborates with Wolfson screening lab
12th Oct 20157:00 amRNSIndependent study of the IONA® test published
2nd Oct 20157:00 amRNSPremaitha appoints Greek distributor
1st Oct 20154:14 pmRNSPatent Infringement Proceedings Update
22nd Sep 20157:00 amRNSFinal Results
22nd Sep 20157:00 amRNSPremaitha signs contract for IONA test in Chile
15th Jul 20157:00 amRNSGrant of Options
13th Jul 20152:04 pmRNSHolding(s) in Company
6th Jul 20157:00 amRNSCQC accreditation for new NIPT lab
2nd Jul 20152:59 pmRNSCompletion of placing to raise £8 million
2nd Jul 20157:00 amRNSProposed placing to raise approximately £8 million
24th Jun 20157:00 amRNSNew IONA test clinical data showcased
22nd Jun 20157:00 amRNSNew contract for IONA® test
19th Jun 20157:00 amRNSTrading Update
4th Jun 20157:00 amRNSAppointment of Chief Financial Officer
5th May 20157:01 amRNSPremaitha Files Robust Defence with UK High Court
29th Apr 20151:53 pmRNSReissue of Options
31st Mar 20157:00 amRNSNew Contract for IONA test in Poland
23rd Mar 20159:53 amRNSLondon NHS trust teams up with Premaitha Health
16th Mar 20159:40 amRNSNotice of Patent Infringement Proceedings
16th Mar 20157:00 amRNSPremaitha Health signs first NIPT agreement
5th Feb 20157:00 amRNSCE Mark and Launch of the IONA test
30th Jan 20157:00 amRNSCommercial Launch Preparation Update
10th Dec 20147:00 amRNSResults for 7 months to 30 September 2014
25th Nov 20147:00 amRNSNotice of Half Year Results and IONA Test Showcase
4th Nov 201412:07 pmRNSResult of AGM
4th Nov 20147:00 amRNSAGM Statement
2nd Oct 20147:00 amRNSGrant of Options
30th Sep 20147:00 amRNSPublication of Annual Report and Notice of AGM
7th Jul 20144:47 pmRNSHolding(s) in Company
4th Jul 20144:28 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSFirst Day of Dealings on AIM
3rd Jul 20143:42 pmRNSChange of Name
3rd Jul 201411:36 amRNSResult of EGM
1st Jul 201410:47 amRNSOpen Offer Oversubcribed
13th Jun 20147:30 amRNSSchedule 1 - ViaLogy Plc
13th Jun 20147:30 amRNSRestoration - ViaLogy Plc
13th Jun 20147:00 amRNSPublication of Admission Document & Lifting of...
13th Jun 20147:00 amRNSDirectorate Change
13th Jun 20147:00 amRNSFinal Results
15th Apr 201412:30 pmRNSSuspension - Vialogy plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.